IL304755A - Treatment methods for amyloidosis - Google Patents

Treatment methods for amyloidosis

Info

Publication number
IL304755A
IL304755A IL304755A IL30475523A IL304755A IL 304755 A IL304755 A IL 304755A IL 304755 A IL304755 A IL 304755A IL 30475523 A IL30475523 A IL 30475523A IL 304755 A IL304755 A IL 304755A
Authority
IL
Israel
Prior art keywords
amyloidosis
treating
methods
Prior art date
Application number
IL304755A
Other languages
English (en)
Hebrew (he)
Original Assignee
Prothena Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prothena Biosciences Ltd filed Critical Prothena Biosciences Ltd
Publication of IL304755A publication Critical patent/IL304755A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical Treatment Of Metals (AREA)
IL304755A 2021-01-29 2023-07-25 Treatment methods for amyloidosis IL304755A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163143728P 2021-01-29 2021-01-29
PCT/IB2022/050785 WO2022162625A1 (en) 2021-01-29 2022-01-29 Methods of treating al amyloidosis

Publications (1)

Publication Number Publication Date
IL304755A true IL304755A (en) 2023-09-01

Family

ID=80222587

Family Applications (1)

Application Number Title Priority Date Filing Date
IL304755A IL304755A (en) 2021-01-29 2023-07-25 Treatment methods for amyloidosis

Country Status (13)

Country Link
US (1) US20250084153A1 (cg-RX-API-DMAC7.html)
EP (1) EP4284829A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024505923A (cg-RX-API-DMAC7.html)
KR (1) KR20230136643A (cg-RX-API-DMAC7.html)
CN (1) CN117098775A (cg-RX-API-DMAC7.html)
AU (1) AU2022213010A1 (cg-RX-API-DMAC7.html)
CA (1) CA3206326A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023002236A1 (cg-RX-API-DMAC7.html)
IL (1) IL304755A (cg-RX-API-DMAC7.html)
JO (1) JOP20230172A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023008835A (cg-RX-API-DMAC7.html)
TW (1) TW202332465A (cg-RX-API-DMAC7.html)
WO (1) WO2022162625A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA55209A (fr) 2019-03-05 2022-01-12 Prothena Biosciences Ltd Procédés de traitement de l'amylose al

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS63446B1 (sr) * 2016-06-30 2022-08-31 Prothena Biosciences Ltd Kompozicije za lečenje amiloidoze
US11382974B2 (en) * 2017-08-01 2022-07-12 The Trustees Of Columbia University In The City Of New York Methods and compositions for treatment of amyloid deposition diseases
MA55209A (fr) * 2019-03-05 2022-01-12 Prothena Biosciences Ltd Procédés de traitement de l'amylose al

Also Published As

Publication number Publication date
AU2022213010A9 (en) 2024-09-26
KR20230136643A (ko) 2023-09-26
AU2022213010A1 (en) 2023-08-17
EP4284829A1 (en) 2023-12-06
TW202332465A (zh) 2023-08-16
MX2023008835A (es) 2023-09-08
CL2023002236A1 (es) 2024-02-09
US20250084153A1 (en) 2025-03-13
JP2024505923A (ja) 2024-02-08
CA3206326A1 (en) 2022-08-04
JOP20230172A1 (ar) 2023-07-27
CN117098775A (zh) 2023-11-21
WO2022162625A1 (en) 2022-08-04

Similar Documents

Publication Publication Date Title
IL284797A (en) Methods of treating addiction
IL286938A (en) Methods for treating neuropathic pain
IL278759A (en) A method for treating clinical depression
IL292678A (en) Methods for treating depressive disorders
IL315503A (en) Treatment methods
SG11202009073WA (en) Methods of treating ttr amyloidosis using ag10
IL287210A (en) Preparations for the treatment of tumors
IL290983A (en) Treatment methods
IL320711A (en) Treatment methods
IL320896A (en) Methods for treating or preventing transthyretin-mediated amyloidosis
IL286040A (en) Methods of treating al amyloidosis
IL289811A (en) A method for treating cancer
IL287250A (en) treatment method
IL314229A (en) Treatment methods for amyloidosis
GB202201824D0 (en) Methods of treatment
GB201918853D0 (en) Methods of treatment
GB202201825D0 (en) Methods of treatment
GB202201819D0 (en) Methods of treatment
EP4444419A4 (en) METHODS OF TREATING LYMPHOEDEMA
IL307291A (en) Methods for treating inflammation
HK40105766A (en) Methods of treating al amyloidosis
HK40097067A (en) Method of treating amyloidosis
IL268111A (en) Methods of treating pain
IL272390A (en) Cancer treatment methods
HK40066836A (en) Methods of treating al amyloidosis